{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:51:19Z","timestamp":1767891079475,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,11,29]],"date-time":"2008-11-29T00:00:00Z","timestamp":1227916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00520-008-0537-7","type":"journal-article","created":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T09:16:05Z","timestamp":1227863765000},"page":"607-612","source":"Crossref","is-referenced-by-count":6,"title":["The role of methadone in opioid rotation\u2014a Polish experience"],"prefix":"10.1007","volume":"17","author":[{"given":"Wojciech","family":"Leppert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,29]]},"reference":[{"key":"537_CR1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5694\/j.1326-5377.2000.tb139323.x","volume":"173","author":"OT Ayonrinde","year":"2000","unstructured":"Ayonrinde OT, Bridge DT (2000) The rediscovery of methadone for cancer pain management. Med J Aust 173:536\u2013540","journal-title":"Med J Aust"},{"key":"537_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1124\/jpet.102.035881","volume":"303","author":"EA Bolan","year":"2002","unstructured":"Bolan EA, Tallarida RJ, Pasternak GW (2002) Synergy between \u03bc opioid ligands: evidence for functional interactions among \u03bc opioid receptor subtypes. J Pharmacol Exp Ther 303:557\u2013562 doi: 10.1124\/jpet.102.035881","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"537_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","volume":"22","author":"E Bruera","year":"2004","unstructured":"Bruera E, Palmer JN, Bosnjak S, Rico MA, Moyano J et al (2004) Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol 22(1):185\u2013192 doi: 10.1200\/JCO.2004.03.172","journal-title":"J Clin Oncol"},{"key":"537_CR4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","volume":"78","author":"E Bruera","year":"1996","unstructured":"Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J (1996) Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 78:852\u2013857 doi:10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","journal-title":"Cancer"},{"issue":"9","key":"537_CR5","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","volume":"19","author":"N Cherny","year":"2001","unstructured":"Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V, Expert Working Group of the European Association of Palliative Care Network (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19(9):2542\u20132554","journal-title":"J Clin Oncol"},{"key":"537_CR6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-3565(25)10630-7","volume":"274","author":"EE Codd","year":"1995","unstructured":"Codd EE, Schank RP, Schupsky JJ, Raffa RB (1995) Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther 274:1263\u20131270","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"537_CR7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0885-3924(99)00086-X","volume":"18","author":"PJ Daeninck","year":"1999","unstructured":"Daeninck PJ, Bruera E (1999) Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage 18(4):303\u2013309 doi: 10.1016\/S0885-3924(99)00086-X","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"537_CR8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00520-005-0839-y","volume":"13","author":"MP Davies","year":"2005","unstructured":"Davies MP (2005) Look before leaping: combined opioids may not be the rave. Support Care Cancer 13(10):769\u2013774 doi: 10.1007\/s00520-005-0839-y","journal-title":"Support Care Cancer"},{"key":"537_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s005200000180","volume":"9","author":"MP Davis","year":"2001","unstructured":"Davis MP, Walsh D (2001) Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer 9:73\u201383 doi: 10.1007\/s005200000180","journal-title":"Support Care Cancer"},{"issue":"10","key":"537_CR10","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.1996.14.10.2836","volume":"14","author":"F Conno De","year":"1996","unstructured":"De Conno F, Groff L, Brunelli C, Zecca E, Ventafridda V, Ripamonti C (1996) Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol 14(10):2836\u20132842","journal-title":"J Clin Oncol"},{"issue":"5","key":"537_CR11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0885-3924(95)90924-C","volume":"10","author":"ND Stoutz De","year":"1995","unstructured":"De Stoutz ND, Bruera E, Suazer-Almazor M (1995) Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10(5):378\u2013384 doi: 10.1016\/0885-3924(95)90924-C","journal-title":"J Pain Symptom Manage"},{"key":"537_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3940(95)11364-3","volume":"187","author":"B Ebert","year":"1995","unstructured":"Ebert B, Andersen S, Krogsgaard-Larsen P (1995) Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett 187:165\u2013168 doi: 10.1016\/0304-3940(95)11364-3","journal-title":"Neurosci Lett"},{"key":"537_CR13","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/cncr.10518","volume":"94","author":"RH Enting","year":"2002","unstructured":"Enting RH, Oldenmenger WH, van der Rijt CCD, Wilms EB, Elfrink EJ, Elswijk I, Sillevis Smitt PAE (2002) A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer 94:3049\u20133056 doi: 10.1002\/cncr.10518","journal-title":"Cancer"},{"issue":"4","key":"537_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1526-4637.2002.02047.x","volume":"3","author":"SM Fishman","year":"2002","unstructured":"Fishman SM, Wilsey B, Mahajan G, Molina P (2002) Methadone reincarnated: novel clinical applications with related concerns. Pain Med 3(4):339\u2013348 doi: 10.1046\/j.1526-4637.2002.02047.x","journal-title":"Pain Med"},{"issue":"5","key":"537_CR15","first-page":"152","volume":"4","author":"G Gannon","year":"1997","unstructured":"Gannon G (1997) The use of methadone in the care of dying. Eur J Palliat Care 4(5):152\u2013158","journal-title":"Eur J Palliat Care"},{"issue":"2","key":"537_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/109662104773709431","volume":"7","author":"G Gazelle","year":"2004","unstructured":"Gazelle G, Fine PG (2004) Methadone for pain. J Palliat Med 7(2):303\u2013304 doi: 10.1089\/109662104773709431","journal-title":"J Palliat Med"},{"issue":"5","key":"537_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0885-3924(99)00083-4","volume":"18","author":"NA Hagen","year":"1999","unstructured":"Hagen NA, Wasylenko E (1999) Methadone: outpatient titration and monitoring strategies in cancer patients. J Pain Symptom Manage 18(5):369\u2013375 doi: 10.1016\/S0885-3924(99)00083-4","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"537_CR18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","volume":"84","author":"GW Hanks","year":"2001","unstructured":"Hanks GW, de Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Roca i Casas J, S\u00e4we J, Twycross RG, Ventafridda V, Expert Working Group of the Research Network of the European Association for Palliative Care (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84(5):587\u2013593","journal-title":"Br J Cancer"},{"issue":"2","key":"537_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpainsymman.2004.04.005","volume":"28","author":"A Kotli\u0144ska-Lemieszek","year":"2004","unstructured":"Kotli\u0144ska-Lemieszek A, \u0141uczak J (2004) Subanesthetic ketamine: an essential adjuvant for intractable cancer pain. J Pain Symptom Manage 28(2):100\u2013102 doi: 10.1016\/j.jpainsymman.2004.04.005","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"537_CR20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3","volume":"82","author":"PG Lawlor","year":"1998","unstructured":"Lawlor PG, Turner KS, Hanson J, Bruera ED (1998) Dose ratio between morphine and methadone in patients with cancer pain. A retrospective study. Cancer 82(6):1167\u20131183 doi: 10.1002\/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3","journal-title":"Cancer"},{"issue":"5","key":"537_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1179\/096992605X75868","volume":"13","author":"W Leppert","year":"2005","unstructured":"Leppert W, Luczak J (2005) The role of methadone in cancer pain treatment\u2014Polish experience. Prog Palliat Care 13(5):269\u2013276 doi: 10.1179\/096992605X75868","journal-title":"Prog Palliat Care"},{"key":"537_CR22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1634\/theoncologist.9-5-571","volume":"9","author":"D Lussier","year":"2004","unstructured":"Lussier D, Huskey AG, Portenoy RK (2004) Adjuvant analgesics in cancer pain management. Oncologist 9:571\u2013591 doi: 10.1634\/theoncologist.9-5-571","journal-title":"Oncologist"},{"issue":"1","key":"537_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jpm.2000.3.49","volume":"3","author":"IL Mancini","year":"2000","unstructured":"Mancini IL, Hanson J, Neumann CM, Bruera E (2000) Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med 3(1):49\u201356 doi: 10.1089\/jpm.2000.3.49","journal-title":"J Palliat Med"},{"issue":"2","key":"537_CR24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0885-3924(03)00259-8","volume":"26","author":"PL Manfredi","year":"2003","unstructured":"Manfredi PL, Foley KM, Payne R, Houde R, Inturissi CE (2003) Parenteral methadone: an essential medication for the treatment of pain. J Pain Symptom Manage 26(2):687\u2013688 doi: 10.1016\/S0885-3924(03)00259-8","journal-title":"J Pain Symptom Manage"},{"key":"537_CR25","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","volume":"86","author":"S Mercadante","year":"1999","unstructured":"Mercadante S (1999) Opioid rotation for cancer pain. Rationale and clinical aspects. Cancer 86:1856\u20131866 doi: 10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","journal-title":"Cancer"},{"issue":"5","key":"537_CR26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0959-8049(97)10053-3","volume":"34","author":"S Mercadante","year":"1998","unstructured":"Mercadante S (1998) Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer 34(5):627\u2013631 doi: 10.1016\/S0959-8049(97)10053-3","journal-title":"Eur J Cancer"},{"key":"537_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1191\/0269216304pm860xx","volume":"18","author":"S Mercadante","year":"2004","unstructured":"Mercadante S (2004) Switching to methadone: \u201cad libitum\u201d or fixed dose ratio? Palliat Med 18:71 doi: 10.1191\/0269216304pm945rr","journal-title":"Palliat Med"},{"issue":"5","key":"537_CR28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00520-003-0440-1","volume":"11","author":"S Mercadante","year":"2003","unstructured":"Mercadante S, Bianchi M, Villari P, Ferrera P, Casuccio A, Fulfaro F, Gebbia V (2003) Opioid plasma concentration during switching from morphine to methadone: preliminary data. Support Care Cancer 11(5):326\u2013331","journal-title":"Support Care Cancer"},{"issue":"3","key":"537_CR29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0885-3924(99)00048-2","volume":"18","author":"S Mercadante","year":"1999","unstructured":"Mercadante S, Casuccio A, Agnello A, Barresi L (1999) Methadone response in advanced cancer patients with pain followed at home. J Pain Symptom Manage 18(3):188\u2013192 doi: 10.1016\/S0885-3924(99)00048-2","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"537_CR30","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1200\/JCO.1999.17.10.3307","volume":"17","author":"S Mercadante","year":"1999","unstructured":"Mercadante S, Casuccio A, Calderone L (1999) Rapid switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol 17(10):3307\u20133312","journal-title":"J Clin Oncol"},{"issue":"11","key":"537_CR31","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1200\/JCO.2001.19.11.2898","volume":"19","author":"S Mercadante","year":"2001","unstructured":"Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P, Gebbia V, Ripamonti C (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19(11):2898\u20132904","journal-title":"J Clin Oncol"},{"issue":"2","key":"537_CR32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0885-3924(03)00258-6","volume":"26","author":"S Mercadante","year":"2003","unstructured":"Mercadante S, Ferrera P, Villari P, Arcuri E (2003) Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage 26(2):769\u2013775 doi: 10.1016\/S0885-3924(03)00258-6","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"537_CR33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00520-004-0650-1","volume":"12","author":"S Mercadante","year":"2004","unstructured":"Mercadante S, Villari P, Ferrera P, Casuccio A (2004) Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer 12(11):762\u2013766 doi: 10.1007\/s00520-004-0650-1","journal-title":"Support Care Cancer"},{"key":"537_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1191\/096813098673619329","volume":"5","author":"J Morley","year":"1998","unstructured":"Morley J, Mankin M (1998) The use of methadone in cancer pain poorly responsive to other opioids. Pain Rev 5:51\u201358 doi: 10.1191\/096813098673619329","journal-title":"Pain Rev"},{"key":"537_CR35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0304-3959(01)00465-1","volume":"96","author":"N Moryl","year":"2002","unstructured":"Moryl N, Santiago-Palma J, Kornick C, Derby S, Fischberg D, Payne R, Manfredi PL (2002) Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain 96:325\u2013328 doi: 10.1016\/S0304-3959(01)00465-1","journal-title":"Pain"},{"issue":"3","key":"537_CR36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0889-8588(02)00017-5","volume":"16","author":"C Ripamonti","year":"2002","unstructured":"Ripamonti C, Bianchi M (2002) The use of methadone for cancer pain. Hematol Oncol Clin North Am 16(3):543\u2013555 doi: 10.1016\/S0889-8588(02)00017-5","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"537_CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/109662104322737278","volume":"7","author":"C Ripamonti","year":"2004","unstructured":"Ripamonti C, Bianchi M, Bruera E (2004) Methadone: an orphan drug? J Palliat Med 7(1):73\u201374 doi: 10.1089\/109662104322737278","journal-title":"J Palliat Med"},{"issue":"10","key":"537_CR38","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1200\/JCO.1998.16.10.3216","volume":"16","author":"C Ripamonti","year":"1998","unstructured":"Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F (1998) Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 16(10):3216\u20133221","journal-title":"J Clin Oncol"},{"key":"537_CR39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.annonc.a059327","volume":"6","author":"C Ripamonti","year":"1995","unstructured":"Ripamonti C, Zecca E, Brunelli C, Rizzio E, Salta L, Lodi F, De Conno F (1995) Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study. Ann Oncol 6:841\u2013843","journal-title":"Ann Oncol"},{"key":"537_CR40","first-page":"324","volume":"8","author":"MA Simmonds","year":"1989","unstructured":"Simmonds MA, Payne R, Richenbacher J, Moran K, Southam NA, Hershey MS (1989) TTS (fentanyl) in the management of pain in patients with cancer. Proc Am Soc Clin Oncol 8:324","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"1","key":"537_CR41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1742-7843.2007.00017.x","volume":"100","author":"E Spina","year":"2007","unstructured":"Spina E, de Leon J (2007) Metabolic drug interactions with newer antipsychotics: a comparative review. Basic Clin Pharmacol Toxicol 100(1):4\u201322 doi: 10.1111\/j.1742-7843.2007.00017.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"537_CR42","first-page":"39","volume":"5","author":"R Twycross","year":"1998","unstructured":"Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Palliat Care 5(2):39\u201345","journal-title":"Eur J Palliat Care"},{"issue":"suppl. 1","key":"537_CR43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0305-7372(96)90075-4","volume":"22","author":"S Watanabe","year":"1996","unstructured":"Watanabe S, Belzile M, Kuehn N, Hanson J, Bruera E (1996) Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations. Cancer Treat Rev 22(suppl. 1):131\u2013136 doi: 10.1016\/S0305-7372(96)90075-4","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"537_CR44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1526-4637.2008.00461.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT (2008) A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med 9(5):595\u2013612 doi: 10.1111\/j.1526-4637.2008.00461.x","journal-title":"Pain Med"},{"issue":"3","key":"537_CR45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT, Richeimer S (2008) Actual and potential drug interactions associated with methadone. Pain Med 9(3):315\u2013344 doi: 10.1111\/j.1526-4637.2006.00289.x","journal-title":"Pain Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-008-0537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-008-0537-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-008-0537-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:07:19Z","timestamp":1738703239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-008-0537-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,29]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s00520-008-0537-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,29]]}}}